Caption Management »

Supernus Pharmaceuticals shares owned by Caption Management

Quarter-by-quarter ownership of Supernus Pharmaceuticals (SUPN) shares owned by Caption Management from 13F filings

Historical chart of Caption Management investment in Supernus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Supernus Pharmaceuticals held by Caption Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Supernus Pharmaceuticals by Caption Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $682k 20k 34.11
2022-03-31 $1.6M 50k 32.30
2021-09-30 $320k 12k 26.67
2020-12-31 $1.5M 58k 25.16
2019-03-31 $681k 19k 35.10
2018-12-31 $3.5M 104k 33.27

More positions owned by Caption Management

Citigroup Com New Put Option (C)
Verizon Communications Put Option (VZ)
Caterpillar Call Option (CAT)
Sarepta Therapeutics Call Option (SRPT)
Metropcs Communications Call Option (TMUS)
Mondelez Intl Cl A Put Option (MDLZ)
Spdr Ser Tr S&p Regl Bkg Put Option (KRE)
Cytokinetics Com New Call Option (CYTK)
AmerisourceBergen Call Option (COR)
Capri Holdings SHS Call Option (CPRI)
United States Steel Corporation Call Option (X)
Viking Therapeutics Call Option (VKTX)
Alnylam Pharmaceuticals Call Option (ALNY)
Adobe Systems Incorporated Put Option (ADBE)
ResMed Call Option (RMD)

View all positions for Caption Management

Top funds holding Supernus Pharmaceuticals

BlackRock
Vanguard Group
Armistice Capital
Dimensional Fund Advisors
Stephens Investment Management Group
Loomis, Sayles and
Jennifer Ranahan
Geode Capital Management
Woodline Partners
Aristotle Capital Boston
Congress Asset Management
Pictet Asset Management Holding SA
Ashford Capital Management
Morgan Stanley
Victory Capital Management

View all funds holding Supernus Pharmaceuticals